Who uses Alamar NULISA?

NULISA panels detect very low levels of proteins in blood, such as brain and inflammation markers, by pairing antibodies with DNA barcodes. It's made by Alamar Biosciences. 79 bioRxiv and medRxiv preprints since April 2025 say they used NULISA, 43 in the last 6 months. Updated daily (as of Nov 16)

Is NULISA use still growing?

New: in preprints since Q2 2025, with 43 in the last 6 months, up from 18 in the six months before.

How does NULISA compare with other affinity proteomics platforms?

NULISA is second, with 25% of their uses in Jun–Nov 2026, up from 12% the year before. Olink leads with 54%.

Preprints in the last 6 months

Growth, Jun–Nov 2026 vs Jun–Nov 2025

Which institutions use NULISA most?

The institutions using NULISA most are University of Pittsburgh, Emory University and Stanford University.

Institutions

  1. University of Pittsburgh7
  2. Emory University6
  3. Stanford University4
  4. Washington University in St. Louis3
  5. University of Oxford3

Where the labs are

  • US63%
  • UK10%
  • Australia6%
  • Germany4%
  • Sweden4%

The lab's institution and country are the corresponding author's.

Latest preprints using NULISA

Who started using NULISA recently?

22 institutions posted their first preprint using NULISA since April 2025 in the last 6 months, including The Jackson Laboratory, University of Wisconsin–Madison and Amsterdam UMC.

  1. The Jackson LaboratoryJul 6, 2026
  2. University of Wisconsin–MadisonAug 31, 2026
  3. Amsterdam UMCJun 16, 2026
  4. Noselab GmbHJun 17, 2026
  5. Feinstein Institutes for Medical ResearchJun 22, 2026
  6. University of BresciaJun 24, 2026
  7. University of New South WalesJul 7, 2026
  8. NYU Grossman School of MedicineJul 8, 2026
  9. Friedrich-Alexander University Erlangen-NürnbergJul 10, 2026
  10. Columbia UniversityJul 31, 2026

An institution counts as new when its first preprint using NULISA since April 2025 was posted in the last 6 months; the date is that first preprint.

What do labs use alongside NULISA?

Preprints using NULISA most often also use NextSeq, Chromium and NovaSeq X. The count is preprints using both.

What is NULISA used for?

Preprints using NULISA are most often in neurology, neuroscience and immunology.

Fields

Neurology 42Neuroscience 9Immunology 7Epidemiology 3Psychiatry and clinical psychology 3Systems biology 2

Where the work was published

  1. Human Genetics and Genomics Advances1
  2. Neurological Research and Practice1
  3. Free Radical Biology and Medicine1
  4. Nature Immunology1
  5. Journal of Clinical Investigation1
  6. European Heart Journal1
How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using NULISA?

Get the PIs behind the preprints: institutions, labs, and how to reach them.

Institutions with the most preprints using NULISA